JENNIFER ASHUN: Open Payments
NPI 1447871504 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,245 in 50 payments from 17 companies in 2025. Trend: 2023 $932 · 2024 $2,942 · 2025 $2,245
Long term medical supply or device loan: $1,082Food & beverage: $1,068Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $1,150 |
| Daiichi Sankyo Inc. | 5 | $228 |
| Incyte Corporation | 2 | $149 |
| Janssen Biotech, Inc. | 6 | $137 |
| Astellas Pharma US Inc | 2 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Gilead Sciences, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: KISQALI, DATROWAY, Monjuvi, Nubeqa, KEYTRUDA, RYBREVANT, Enhertu, Trodelvy.
Industry payments across TX — which companies pay providers there.
